Wells Fargo & Company MN Invests $3.04 Million in Everus (NYSE:ECG)

Wells Fargo & Company MN bought a new position in shares of Everus (NYSE:ECG - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 46,211 shares of the company's stock, valued at approximately $3,038,000. Wells Fargo & Company MN owned approximately 0.09% of Everus at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in ECG. SRS Capital Advisors Inc. bought a new stake in shares of Everus during the 4th quarter valued at $26,000. Principal Securities Inc. bought a new stake in shares of Everus during the fourth quarter valued at about $27,000. HighMark Wealth Management LLC purchased a new stake in shares of Everus in the fourth quarter worth about $28,000. Crews Bank & Trust bought a new position in shares of Everus in the fourth quarter valued at approximately $29,000. Finally, Mendota Financial Group LLC purchased a new position in Everus during the fourth quarter valued at approximately $36,000.

Insiders Place Their Bets

In other Everus news, Director Rocca Michael Della bought 1,050 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average price of $47.56 per share, for a total transaction of $49,938.00. Following the transaction, the director now directly owns 2,027 shares in the company, valued at $96,404.12. This trade represents a 107.47 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Edward A. Ryan purchased 1,400 shares of the stock in a transaction on Tuesday, February 25th. The stock was acquired at an average cost of $38.02 per share, with a total value of $53,228.00. Following the completion of the purchase, the director now directly owns 14,928 shares of the company's stock, valued at $567,562.56. The trade was a 10.35 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 3,750 shares of company stock valued at $153,853 over the last 90 days. Insiders own 0.21% of the company's stock.

Everus Trading Up 0.0 %

ECG traded up $0.01 on Friday, reaching $40.98. The company had a trading volume of 437,834 shares, compared to its average volume of 731,564. Everus has a 52-week low of $31.38 and a 52-week high of $77.93. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.58 and a quick ratio of 1.50. The business has a 50 day moving average of $38.92.

Everus (NYSE:ECG - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 earnings per share for the quarter, missing the consensus estimate of $0.73 by ($0.06). Sell-side analysts forecast that Everus will post 2.49 earnings per share for the current fiscal year.

Analyst Ratings Changes

ECG has been the topic of several recent analyst reports. Oppenheimer increased their target price on shares of Everus from $70.00 to $80.00 and gave the stock an "outperform" rating in a research note on Tuesday, January 7th. Stifel Nicolaus lowered their price objective on Everus from $67.00 to $55.00 and set a "buy" rating on the stock in a research report on Wednesday, April 9th.

Everus Company Profile

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.